Company Filing History:
Years Active: 2025
Title: Innovations of Emma-Louise Elizabeth Moore
Introduction
Emma-Louise Elizabeth Moore is a notable inventor based in Mississauga, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on enhancing the efficacy and delivery of medications.
Latest Patents
Emma-Louise holds 1 patent for her invention titled "Crystalline forms of dexamethasone dimers and uses thereof." This patent features polymorphs of a prodrug dimer of dexamethasone linked at the 21-C and 21'-C carbons via a carbonate-triethylene glycol-carbonate linker. The disclosure also includes pharmaceutical compositions and articles comprising these polymorphs, which are utilized in the treatment of various diseases or conditions through the extended or controlled release of dexamethasone.
Career Highlights
Emma-Louise is currently associated with Ripple Therapeutics Corporation, where she applies her expertise in pharmaceutical innovation. Her work is pivotal in advancing therapeutic options for patients, showcasing her commitment to improving healthcare outcomes.
Collaborations
Emma-Louise collaborates with talented professionals in her field, including Ian Charles Parrag and Matthew Alexander John Statham. These partnerships enhance the research and development efforts at Ripple Therapeutics Corporation.
Conclusion
Emma-Louise Elizabeth Moore is a pioneering inventor whose work in pharmaceutical innovations is making a significant impact. Her contributions to drug formulation and delivery systems are vital for advancing medical treatments.